Cargando…
Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules
Atherosclerosis-predominant vasculopathy is a common complication of diabetes with high morbidity and high mortality, which is ruining the patient's daily life. As is known to all, traditional Chinese medicine (TCM) SHENQI compound and western medicine rosiglitazone play an important role in th...
Autores principales: | Gao, Hong, Duan, Yuhong, Fu, Xiaoxu, Xie, Hongyan, Liu, Ya, Yuan, Haipo, Zhou, Mingyang, Xie, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283585/ https://www.ncbi.nlm.nih.gov/pubmed/30521536 http://dx.doi.org/10.1371/journal.pone.0207683 |
Ejemplares similares
-
Efficacy and safety of shenqi compound for the treatment of diabetic macroangiopathy: A protocol for systematic review and meta-analysis
por: Hu, Zhipeng, et al.
Publicado: (2020) -
Effect of Shenqi compound on inflammatory markers and glycemic measures among diabetes mellitus: A protocol for systematic review and meta-analysis
por: Yang, Yan, et al.
Publicado: (2020) -
Qingfei Paidu decoction for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials
por: Zhang, Yuan, et al.
Publicado: (2020) -
Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
por: Rahman, Sayeeda, et al.
Publicado: (2009) -
The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
por: Zhang, Zehua, et al.
Publicado: (2022)